Pharmaron Beijing Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pharmaron Beijing Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10922
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pharmaron Beijing Co Ltd (Pharmaron) is a life science service company that provides drug research and development services in the areas of chemistry, biology, pharmacology, DMPK, toxicology, and chemical development. The company’s service offerings include synthetic, medicinal and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development, and clinical development services. Pharmaron caters to small and large biotechnology and pharmaceutical companies. The company has operations chemical manufacturing, drug R&D, radiolabelled chemistry and metabolism, and clinical research facilities in the US, the UK, and China. Pharmaron is headquartered in Beijing, China.

Pharmaron Beijing Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pharmaron Beijing Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Pharmaron Acquires Hoddesdon UK Site from Merck Sharpe & Dohme 11
Venture Financing 12
Xceleron Raises US$2.4 Million In Venture Financing 12
Private Equity 13
Pharmaron Receives Investment Commitment from CITIC Merger & Acquisition Fund and Legend Capital 13
Bridgepoint Development Capital Acquires Quotient Clinical From Quotient Bioresearch 14
TA Associates Acquires Drug Development Services Provider, Quotient Bioresearch 15
Partnerships 16
Pharmaron and CR MedIcon Enter into Agreement 16
Xceleron Enters Into Agreement With Crystal Pharmatech For Early Clinical Development 17
Pharmaron Enters Into Drug Discovery Agreement With AstraZeneca 18
Quotient Clinical Enters Into Co-Development Agreement With Capsugel 19
Asset Transactions 20
LGC Genomics To Acquire Bioanalytical Sciences Business Of Quotient BioResearch 20
Acquisition 21
Pharmaron Acquires Majority Stake in SNBL CPC from SNBL 21
Pharmaron Acquires Xceleron 22
Pharmaron Acquires Quotient Bioresearch 23
Pharmaron Beijing Co Ltd – Key Competitors 24
Pharmaron Beijing Co Ltd – Key Employees 25
Pharmaron Beijing Co Ltd – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Other Significant Developments 28
Sep 22, 2017: Pharmaron Launches New Website 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmaron Beijing Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Pharmaron Beijing Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Pharmaron Acquires Hoddesdon UK Site from Merck Sharpe & Dohme 11
Xceleron Raises US$2.4 Million In Venture Financing 12
Pharmaron Receives Investment Commitment from CITIC Merger & Acquisition Fund and Legend Capital 13
Bridgepoint Development Capital Acquires Quotient Clinical From Quotient Bioresearch 14
TA Associates Acquires Drug Development Services Provider, Quotient Bioresearch 15
Pharmaron and CR MedIcon Enter into Agreement 16
Xceleron Enters Into Agreement With Crystal Pharmatech For Early Clinical Development 17
Pharmaron Enters Into Drug Discovery Agreement With AstraZeneca 18
Quotient Clinical Enters Into Co-Development Agreement With Capsugel 19
LGC Genomics To Acquire Bioanalytical Sciences Business Of Quotient BioResearch 20
Pharmaron Acquires Majority Stake in SNBL CPC from SNBL 21
Pharmaron Acquires Xceleron 22
Pharmaron Acquires Quotient Bioresearch 23
Pharmaron Beijing Co Ltd, Key Competitors 24
Pharmaron Beijing Co Ltd, Key Employees 25
Pharmaron Beijing Co Ltd, Other Locations 27
Pharmaron Beijing Co Ltd, Subsidiaries 27

List of Figures
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmaron Beijing Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pharmaron Beijing Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Pharmaron Beijing Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Capital Stage AG (CAP):企業財務及び戦略的SWOT分析
    Summary Capital Stage AG (Capital Stage) is a private equity firm that invests in renewable energy projects. It operates solar parks and clean and environment-friendly power station capacities independently. The firm focuses its investments on the acquisition of turnkey projects or exisiting install …
  • PharmaGap, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' PharmaGap, Inc. Mergers and Acq …
  • Circuit Electronic Industries Public Co.,Ltd. (CIRKIT):企業の財務及び戦略的SWOT分析
    Summary Circuit Electronic Industries Public Co.,Ltd. (CEI) is an electronic equipment company that manufactures and tests integrated circuits for generating auto parts, communication devices, computers, and electronic appliances. The company also offers manufacturing services like semiconductor pac …
  • Cossette, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cossette, Inc. Mergers and Acqu …
  • Pearl Polymers Ltd.:企業の戦略・SWOT・財務情報
    Pearl Polymers Ltd. - Strategy, SWOT and Corporate Finance Report Summary Pearl Polymers Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PolyMedix, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' PolyMedix, Inc. Mergers and Acq …
  • Exelon Corporation:企業の戦略・SWOT・財務分析
    SummaryExelon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Workspace Group PLC:企業の戦略・SWOT・財務分析
    SummaryWorkspace Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • Frontier Energy Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Frontier Energy Corporation Mer …
  • Huiyin Household App. (Hold.) Co., Ltd.:戦略・SWOT・企業財務分析
    Huiyin Household App. (Hold.) Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Huiyin Household App. (Hold.) Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Renishaw Plc (RSW):企業の財務・戦略的SWOT分析
    Summary Renishaw Plc (Renishaw) is a medical device company that designs, manufactures and markets measurement, motion control, spectroscopy and precision machining products. The company offers precision measurement and process control, position and motion control, 3D laser scanning and measurement, …
  • Colonial Penn Life Insurance Company:企業の戦略・SWOT・財務情報
    Colonial Penn Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Colonial Penn Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Mubadala Development Company PJSC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mubadala Development Company PJ …
  • Power Finance Corporation Ltd.:企業の戦略・SWOT・財務分析
    Power Finance Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Power Finance Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Intrinsic Bioprobes, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Intrinsic Bioprobes, Inc. Merge …
  • Kane Biotech Inc. (KNE):(医療機器分野)企業M&A及び提携動向
    Summary Kane Biotech Inc. (Kane Biotech) is a biotechnology company. The company develops and commercializes products that prevent and remove microbial biofilms. It uses patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or d …
  • Pembina Pipeline Corporation (PPL):企業概要、財務及び戦略的SWOT分析
    Summary Pembina Pipeline Corporation (Pembina) is an energy transportation and service provider. The company owns and operates pipelines, which transport conventional and synthetic crude oil and natural gas liquids produced in western Canada; oil sands, heavy oil and diluent pipelines; gas processin …
  • State Atomic Energy Corporation Rosatom(環境技術分野):企業M&A動向
    Summary State Atomic Energy Corporation Rosatom (ROSATOM) is a nuclear corporation. The corporation manages all the nuclear assets of the Russian Federation. It implements the government’s nuclear policies, provides control over the use of atomic energy, and ensures stable operation of civil and def …
  • Ihara Chemical Industry Co., Ltd. (4989):企業の財務及び戦略的SWOT分析
    Summary Ihara Chemical Industry Co., Ltd. (ICI) is a chemical company that conducts research and develops, manufactures and sells fine chemicals. The company offers gricultural chemicals, fine chemicals and curing agents. ICI’s agricultural chemicals include herbicide, fungicide, acaricide and PGR. …
  • BRF S.A.:企業のM&A・提携・投資分析
    BRF S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BRF S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆